Skip to content

Author

Shichong Liu

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

FerrGAT: Multi-Task Pre-Training of Graph Attention Networks for Low-Data Molecular Activity Prediction

Predicting molecular bioactivity in low-data regimes remains a central challenge in computational drug discovery, where labeled compounds for specialized tasks are scarce while related datasets are abundant. Here, we propose FerrGAT, a graph attention network framework that addresses this challenge through domain-relevant multi-task pre-training and dual-channel molecular representation learning. FerrGAT first pre-trains a shared GAT encoder on three mechanistically related tasks—antioxidant activity (GST inhibition, 245 compounds from ChEMBL target CHEMBL2095173; 83 active/162 inactive), kinase inhibition (3000 compounds spanning AXL, EGFR and VEGFR2 from ChEMBL; 2240 active/760 inactive), and cellular toxicity (7265 compounds from the Tox21 NR-AhR endpoint; 309 active/6956 inactive)—then transfers the learned representations to a target task via differential learning rate fine-tuning. The architecture fuses atom-level graph features from multi-head attention message passing with global physicochemical descriptors through a learned projection and provides built-in interpretability via attention weight visualization at the atomic level. We evaluated FerrGAT on ferroptosis inhibitor prediction as a representative low-data molecular classification task (1052 compounds from ChEMBL targets GPX4 and HMOX1 combined with 63 literature- and FerrDb-curated ferroptosis modulators; 409 active/643 inactive). In 5-fold cross-validation, FerrGAT achieved an AUC of 0.906, outperforming Morgan fingerprint baselines, including Random Forest (0.877), XGBoost (0.871), and an SVM (0.873). Ablation studies confirmed that domain-relevant pre-training improved AUC by 2.5% over training from scratch, while pre-training on unrelated tasks degraded performance, highlighting the importance of task-domain alignment. Applied to virtual screening of 30 FDA-approved tyrosine kinase inhibitors, the model identified Bemcentinib (AXL inhibitor, score = 0.918) as a top candidate, validated by AutoDock Vina molecular docking (−8.51 kcal/mol) and independent experimental evidence, including lipid peroxidation assays, Western blot, and cellular thermal shift analysis. These results demonstrate that domain-aware transfer learning with graph attention networks provides an effective and interpretable framework for molecular property prediction in data-limited scenarios.

Shichong Liu, Siqi Wei, Jian Zhao et al. · 0 citations